KI
WST icon

Kalmar Investments’s West Pharmaceutical WST Stock Holding History

Kalmar Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$9.66M Sell
118,331
-577,645
-83% -$48.3M 2.18% 6
2016
Q4 		$59M Sell
695,976
-91,529
-12% -$7.2M 3.04% 1
2016
Q3 		$58.7M Sell
787,505
-43,355
-5% -$3.44M 2.68% 1
2016
Q2 		$63M Sell
830,860
-135,333
-14% -$9.85M 2.78% 1
2016
Q1 		$67M Sell
966,193
-487,885
-34% -$29.4M 2.75% 1
2015
Q4 		$87.6M Sell
1,454,078
-29,139
-2% -$1.75M 2.14% 2
2015
Q3 		$80.3M Sell
1,483,217
-569,206
-28% -$33.2M 1.89% 3
2015
Q2 		$119M Sell
2,052,423
-62,715
-3% -$3.5M 2.26% 2
2015
Q1 		$127M Sell
2,115,138
-183,807
-8% -$9.8M 2.37% 2
2014
Q4 		$122M Sell
2,298,945
-35,841
-2% -$1.79M 2.27% 2
2014
Q3 		$105M Buy
2,334,786
+41,645
+2% +$1.77M 1.99% 2
2014
Q2 		$96.7M Buy
2,293,141
+337,538
+17% +$14.5M 1.66% 7
2014
Q1 		$86.1M Sell
1,955,603
-27,544
-1% -$1.3M 1.45% 11
2013
Q4 		$97.3M Sell
1,983,147
-5,005
-0.3% -$234K 1.62% 8
2013
Q3 		$81.8M Sell
1,988,152
-14,940
-0.7% -$570K 1.45% 13
2013
Q2 		$70.4M Buy
+2,003,092
New +$65.9M 1.38% 11

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Kalmar Investments's WST Position: Q1 2017 in Review

Kalmar Investments reduced its West Pharmaceutical (WST) stake by 83% in Q1 2017, selling an estimated $48.3M and leaving 118,331 shares worth $9.66M. The position accounts for 2.18% of the portfolio, ranked #6.

Kalmar Investments first reported a position in WST in Q2 2013 and has held it in 16 quarters since. The position peaked at $127M in Q1 2015. 295 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • Kalmar Investments held 118,331 shares of West Pharmaceutical worth $9.66M as of Q1 2017.
  • Kalmar Investments sold 577,645 West Pharmaceutical shares in Q1 2017, an estimated $48.3M.
  • West Pharmaceutical made up 2.18% of Kalmar Investments's portfolio in Q1 2017, its #6 holding.
  • Kalmar Investments first reported a position in West Pharmaceutical in Q2 2013 and has held it in 16 quarters since.
  • Kalmar Investments's West Pharmaceutical position peaked at $127M in Q1 2015.
  • 295 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.